Teen cannabis study seeks biomarkers for relapse risk
NCT ID NCT05396638
First seen May 06, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study looks at how cannabis use changes the body's natural endocannabinoid and opioid systems in 30 adolescents aged 14-25 who use cannabis at least twice a week. Researchers measure cannabinoid and endorphin levels in blood to find biomarkers that might predict which teens will relapse and which will stay sober. The goal is to better understand cannabis's effects on the brain and improve treatment approaches.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.